Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 789406, 11 pages
http://dx.doi.org/10.1155/2014/789406
Research Article

The Combined Extract of Purple Waxy Corn and Ginger Prevents Cataractogenesis and Retinopathy in Streptozotocin-Diabetic Rats

1Department of Physiology and Graduate School (Neuroscience Program), Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
2Integrative Complementary Alternative Medicine Research and Development Center, Khon Kaen University, Khon Kaen 40002, Thailand
3Department of Physiology, Faculty of Medicine, Khon Kaen Unieversity, Khon Kaen 40002, Thailand
4Faculty of Agriculture, Khon Kaen University, Khon Kaen 40002, Thailand

Received 20 October 2014; Revised 12 December 2014; Accepted 14 December 2014; Published 31 December 2014

Academic Editor: Jing Yi

Copyright © 2014 Paphaphat Thiraphatthanavong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Engerman and T. S. Kern, “Hyperglycemia as a cause of diabetic retinopathy,” Metabolism, vol. 35, supplement 1, no. 4, pp. 20–23, 1986. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Pollreisz and U. Schmidt-Erfurth, “Diabetic cataract—pathogenesis, epidemiology and treatment,” Journal of Ophthalmology, vol. 2010, Article ID 608751, 8 pages, 2010. View at Publisher · View at Google Scholar
  3. I. G. Obrosova, S. S. M. Chung, and P. F. Kador, “Diabetic cataracts: mechanisms and management,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 172–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Ding and T. Y. Wong, “Current epidemiology of diabetic retinopathy and diabetic macular edema,” Current Diabetes Reports, vol. 12, no. 4, pp. 346–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Y. W. Lee and S. S. M. Chung, “Contributions of polyol pathway to oxidative stress in diabetic cataract,” The FASEB Journal, vol. 13, no. 1, pp. 23–30, 1999. View at Google Scholar · View at Scopus
  6. S. A. Madsen-Bouterse and R. A. Kowluru, “Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. G. Obrosova and P. F. Kador, “Aldose reductase/polyol inhibitors for diabetic retinopathy,” Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 1389–2010, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. R. Drel, P. Pacher, T. K. Ali et al., “Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis,” International Journal of Molecular Medicine, vol. 21, no. 6, pp. 667–676, 2008. View at Google Scholar · View at Scopus
  9. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura et al., “Preventive effect of Zea mays L. (Purple Waxy Corn) on experimental diabetic cataract,” BioMed Research International, vol. 2014, Article ID 507435, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Morimitsu, K. Kubota, T. Tashiro, E. Hashizume, T. Kamiya, and T. Osawa, “Inhibitory effect of anthocyanins and colored rice ondiabetic cataract formation in the rat lenses,” International Congress Series, vol. 1245, pp. 503–508, 2002. View at Publisher · View at Google Scholar
  11. M. Saraswat, P. Suryanarayana, P. Y. Reddy, M. A. Patil, N. Balakrishna, and G. B. Reddy, “Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats,” Molecular Vision, vol. 16, pp. 1525–1537, 2010. View at Google Scholar · View at Scopus
  12. Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, “Preventive and protective properties of Zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 516870, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, “Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats,” Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2092–2099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  16. L. Góth, “A simple method for determination of serum catalase activity and revision of reference range,” Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143–151, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, “Selenium: biochemical role as a component of glatathione peroxidase,” Science, vol. 179, no. 4073, pp. 588–590, 1973. View at Publisher · View at Google Scholar · View at Scopus
  18. M. B. Patel and S. M. Mishra, “Aldose reductase inhibitory activity and anti catraract potential of some traditionally acclaimed antidiabetic medicinal plants,” Oriental Pharmacy and Experimental Medicine, vol. 9, no. 3, pp. 245–251, 2009. View at Publisher · View at Google Scholar
  19. R. Agarwal, I. Iezhitsa, N. A. Awaludin et al., “Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation,” Experimental Eye Research, vol. 110, pp. 35–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. M. Martin, P. Roon, T. K. van Ells, V. Ganapathy, and S. B. Smith, “Death of retinal neurons in streptozotocin-induced diabetic mice,” Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3330–3336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. H. W. van Dijk, F. D. Verbraak, P. H. B. Kok et al., “Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes,” Investigative Ophthalmology and Visual Science, vol. 51, no. 7, pp. 3660–3665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. S. Kern and A. J. Barber, “Retinal ganglion cells in diabetes,” Journal of Physiology, vol. 586, no. 18, pp. 4401–4408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. A. Ramadan, “Sorbitol-induced diabetic-like retinal lesions in rats: microscopic study,” American Journal of Pharmacology and Toxicology, vol. 2, no. 2, pp. 89–97, 2007. View at Publisher · View at Google Scholar
  24. B. Özmen, D. Özmen, E. Erkin, I. Güner, S. Habif, and O. Baymdir, “Lens superoxide dismutase and catalase activities in diabetic cataract,” Clinical Biochemistry, vol. 35, no. 1, pp. 69–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. B. M. Reddy, R. Tammali, R. Mishra, S. Srivastava, S. K. Srivastava, and K. V. Ramana, “Aldose reductase deficiency protects sugar-induced lens opacification in rats,” Chemico-Biological Interactions, vol. 191, no. 1–3, pp. 346–350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura et al., “Preventive effect of Zea mays L. (purple waxy corn) on experimental diabetic cataract,” BioMed Research International, vol. 2014, Article ID 507435, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. I. G. Obrosova and P. F. Kador, “Aldosereductase/polyol inhibitors for diabetic retinopathy,” Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 373–385, 2011. View at Publisher · View at Google Scholar
  28. P. Maher and A. Hanneken, “Flavonoids protect retinal ganglion cells from oxidative stress-induced death,” Investigative Ophthalmology and Visual Science, vol. 46, no. 12, pp. 4796–4803, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Stefek, “Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract,” Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69–77, 2011. View at Publisher · View at Google Scholar
  30. S. F. Nabavi, S. Habtemariam, M. Daglia, N. Shafighi, A. J. Barber, and S. M. Nabavi, “Anthocyanins as a potential therapy for diabetic retinopathy,” Current Medicinal Chemistry, vol. 22, no. 1, pp. 51–58, 2014. View at Publisher · View at Google Scholar
  31. A. H. Rahmani, F. M. Al Shabrmi, and S. M. Aly, “Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities,” International Journal of Physiology, Pathophysiology and Pharmacology, vol. 6, no. 2, pp. 125–136, 2014. View at Google Scholar
  32. H. Watanabe, H. Kosano, and H. Nishigori, “Steroid-induced short term diabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation,” Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1846–1852, 2000. View at Google Scholar · View at Scopus
  33. E. R. James, “The etiology of steroid cataract,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 5, pp. 403–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Greaves, Histopathological of Preclinical Toxicity Studies, Elsevier, New York, NY, USA, 3rd edition, 2007.